The trial, conducted over two years, gave 394 patients one of five treatment options. These were 150mg Zilebesiran (the injection-based medication) every 6 months, 300mg Zilebesiran every 6 months, ...

Scientists have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new ...

A remarkable week for Professor Andrew Livingston saw him recognised with two significant accolades: a prestigious Lifetime ...

Queen Mary University of London has today, 20 June 2025, signed an agreement with the Department of Health and Social Care ...

Queen Mary University of London, the University of Liverpool and King’s College London met with His Excellency Prabowo ...

Workers from lower socio-economic backgrounds face a triple disadvantage in the workplace, according to new research by Queen ...

Expert panellists from sectors including banking and government have recognised Queen Mary University of London’s innovation ...

Queen Mary University of London has climbed 35 places in two years in the QS World University Rankings, firmly establishing ...

Dr Alexander Stoffel, Postdoctoral Research Fellow in the School of Politics and International Relations, is working to ...

The research, published in Nature, gives an opportunity for health-care systems to pinpoint where their region sits on this ...

Tilli Tansey, Emeritus Professor of Medical History and Pharmacology in the William Harvey Research Institute at Queen Mary ...

Researchers have unveiled a groundbreaking robotic hand, the F-TAC Hand, which integrates high-resolution tactile sensing ...